FDA Watch: AI-Based Sepsis Prediction Test Receives FDA Authorization
Prenosis claims its test can detect the presence of the often deadly condition within 24 hours of a hospitalization
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Prenosis claims its test can detect the presence of the often deadly condition within 24 hours of a hospitalization
From - Diagnostic Testing & Emerging Technologies
The majority of U.K. clinical genetics services report that they recontact patients or family members about new findings relevant to…
From - Diagnostic Testing & Emerging Technologies
On the heels of last week's White House Precision Medicine Summit, new research findings suggest that a personalized approach can…
From - Diagnostic Testing & Emerging Technologies
Real-time genomic surveillance is possible in resource-limited settings to monitor infectious disease outbreaks, according to…
From - Diagnostic Testing & Emerging Technologies
Prostate specific antigen (PSA) testing varies significantly by physician specialty, according to a research letter published online Feb. 8 in…
From - Diagnostic Testing & Emerging Technologies
The future of cystic fibrosis (CF) diagnosis is in sight. Testing for the genetic disease helped to fuel the first wave of clinical molecular diagnostics, and now an assay developed by…